Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 13.33% | 5.96% | 24.12% | 9.95% | -6.26% |
Total Depreciation and Amortization | -31.53% | 26.62% | -10.24% | 8.52% | 28.88% |
Total Amortization of Deferred Charges | -7.69% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Non-Cash Items | -47.22% | -27.86% | 8.14% | 1.28% | -7.18% |
Change in Net Operating Assets | 21.89% | -211.21% | 83.03% | -211.52% | -33.81% |
Cash from Operations | 10.16% | -8.44% | 39.36% | -38.50% | -26.99% |
Capital Expenditure | -225.98% | -41.11% | 47.67% | 41.10% | 9.32% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 100.12% | -122.37% | 199.60% | -67.59% | 134.36% |
Cash from Investing | 93.33% | -122.92% | 204.46% | -67.88% | 133.86% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 27.82% | -62.31% | 53.55% | -424.55% | -2.80% |
Issuance of Common Stock | -98.21% | -85.75% | 9,725.00% | 300.00% | -96.55% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 200.00% | -- | -- |
Cash from Financing | 17.41% | -400.79% | 121.95% | -426.61% | -39.74% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 36.10% | -234.87% | 222.66% | -194.16% | 113.75% |